Zobrazeno 1 - 10
of 26
pro vyhledávání: '"O. V. Dralova"'
Publikováno v:
Сеченовский вестник, Vol 0, Iss 4, Pp 64-75 (2022)
The article reviews modern anti-obesity drugs to identify new trends in effective and safe risk factors reduction (diabetes, cardiovascular and musculoskeletal diseases, cancer). Some anti-obesity drugs have a high risk of adverse effects on the CNS
Externí odkaz:
https://doaj.org/article/843ae8d8cea3423c8d09c08dd051707d
Autor:
O. V. Dralova, M. L. Maksimov
Publikováno v:
Сеченовский вестник, Vol 11, Iss 1, Pp 47-54 (2022)
RETRACTED ARTICLERational antihypertensive therapy is effective in the prevention of cardiovascular events and progression of organ damage. When choosing an antihypertensive drug to evaluate the efficacy the likelihood of side effects and benefits of
Externí odkaz:
https://doaj.org/article/65222dd5e5b445d0ba71b59767ee8809
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 7, Pp 139-150 (2017)
Aim. To assess efficacy and safety of double combinations (angiotensine converting enzyme inhibitor (ACEi) + indapamide) and triple combinations (ACEi + statin + indapamide) in arterial hypertnesion (AH) patients with dyslipidemia (DL).Material and m
Externí odkaz:
https://doaj.org/article/67ac042174d74829b13fc868e90d2c59
Publikováno v:
Медицинский совет, Vol 0, Iss 3, Pp 72-78 (2016)
The high prevalence of obesity is a serious medical and social problem conditioned by urbanization, reduced physical activity and availability of high-calorie food. All over the world, the prevalence of obesity has been steadily growing over the last
Externí odkaz:
https://doaj.org/article/806f45386a94426cafa1e806cab697b0
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 1, Iss 1, Pp 36-41 (2016)
Background: Due to high prevalence of obesity that has turned into enormous economic and social burden, studies aimed at assessment of damages caused by this medico-social problem are seen as very important in the last years. Aim: To assess economic
Externí odkaz:
https://doaj.org/article/04e6c30207d04693a707eb8107052242
Autor:
O. V. Dralova, M. L. Maksimov
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 7, Iss 4, Pp 468-472 (2016)
Pharmacotherapy optimization in patients with arterial hypertension and gout is very important. Achievement of the target blood pressure levels is possible with the use of combinations of effective antihypertensive drugs with neutral metabolic profil
Externí odkaz:
https://doaj.org/article/ab84b34c4d344ea5a3d9710b61fc14b3
Autor:
O. V. Dralova, M. L. Maksimov
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 7, Iss 4, Pp 501-506 (2016)
Blood pressure (BP) control in patients with chronic kidney disease is one of the most pressing problems in modern cardiology and nephrology. Perindopril therapy reduces cardiovascular risk in patients with arterial hypertension and nephropathy, prov
Externí odkaz:
https://doaj.org/article/02ffea56dfde4c6db6465256a4d70aff
Publikováno v:
Медицинский совет, Vol 0, Iss 10, Pp 12-16 (2014)
Currently, arterial hypertension (AH) and atherosclerosis are the most significant risk factors for cerebral complications including ischemic stroke, which requires adequate therapeutic interventions for primary and secondary prevention [1].
Externí odkaz:
https://doaj.org/article/b636de168960457583d77ac60862d3a0
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 9, Iss 2, Pp 115-124 (2010)
Chronic activation of renin-angiotensin-aldosterone system (RAAS) is characterised by vasoconstriction, increased total peripheral vascular resistance, organ and tissue hypoperfusion, fluid detention, increased circulatory volume, increased myocardia
Externí odkaz:
https://doaj.org/article/458799b52eeb485591778b4fd6e99527
Autor:
O. V. Dralova, M. L. Maksimov
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 7, Iss 4, Pp 501-506 (2016)
Blood pressure (BP) control in patients with chronic kidney disease is one of the most pressing problems in modern cardiology and nephrology. Perindopril therapy reduces cardiovascular risk in patients with arterial hypertension and nephropathy, prov